Cargando…
State of affairs regarding targeted pharmacological therapy of cancers metastasized to the brain
In 1999 a visionary short article by The Wall Street Journal writers Robert Langreth and Michael Waldholz popularized the new term “personalized medicine,” that is to say, the targeting of drugs to each unique genetic profile. From today’s perspective, targeted approaches have clearly found the wide...
Autores principales: | Steiger, Hans-Jakob, Vollmer, Kathrin, Rogers, Susanne, Schwyzer, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492578/ https://www.ncbi.nlm.nih.gov/pubmed/35902427 http://dx.doi.org/10.1007/s10143-022-01839-8 |
Ejemplares similares
-
Spinal Metastases of Supratentorial Glioblastoma with Primitive Neuronal Component
por: Vollmer, Kathrin, et al.
Publicado: (2019) -
Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis
por: Beez, Thomas, et al.
Publicado: (2017) -
Targeted Therapies in Brain Metastases
por: Lin, Nancy U.
Publicado: (2013) -
The Intervention of the State in Medical Affairs
Publicado: (1883) -
Targeted Therapies for Melanoma Brain Metastases
por: Berghoff, Anna S., et al.
Publicado: (2017)